AaiPharma Inc., of Wilmington, N.C., named Philip Tabbiner CEO and a member of its board, effective July 1.
Active Biotech AB, of Lund, Sweden, elected H kan ström to its board.
Affymax Inc., of Palo Alto, Calif., appointed Helen Kim chief business officer.
AlleCure Corp., of Valencia, Calif., appointed Kenneth Denich director of business development.
Allos Therapeutics Inc., of Westminster, Colo., appointed Daniel Hudspeth vice president and chief financial officer.
Altachem Pharma Ltd., of Edmonton, Alberta, added Selvaraj Naicker as senior vice president of drug development and Thomas Woo vice president of product development.
AnorMED Inc., of Vancouver, British Columbia, appointed Paul Brennan vice president, business development, Renato Skerlj vice president, chemistry, and Robert Schooley to its scientific advisory board.
AnVil Inc., of Burlington, Mass., named Kurt Thearling director, engineering, and Natasha Markuzon informatics scientist.
Applied Molecular Evolution Inc., of San Diego, appointed Clive Meanwell to its board.
Array BioPharma Inc., of Boulder, Colo., appointed John Moore vice president and general counsel.